https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
CaCdr2p ATPase activity was not impaired by the compound. β-lapachone is a promising drug candidate to be used as an adjuvant in the treatment of candidiasis caused by fluconazole-resistant C. albicans strains. β-lapachone is a promising drug candidate to be used as an adjuvant in the treatment of candidiasis caused by fluconazole-resistant C. albicans strains. Candida glabrata is an emerging pathogen with the ability to develop tolerance and resistance to azole antifungals, which creates uncertainty about the usefulness of antifung
Beğen
Yorum Yap
Paylaş
